Bruce C. Cozadd

2021

In 2021, Bruce C. Cozadd earned a total compensation of $15.7M as Chairperson and CEO at Jazz Pharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,163,400
Salary$1,077,254
Stock Awards$13,414,116
Other$24,541
Total$15,679,311

Cozadd received $13.4M in stock awards, accounting for 86% of the total pay in 2021.

Cozadd also received $1.2M in non-equity incentive plan, $1.1M in salary and $24.5K in other compensation.

Rankings

In 2021, Bruce C. Cozadd's compensation ranked 491st out of 12,415 executives tracked by ExecPay. In other words, Cozadd earned more than 96.0% of executives.

ClassificationRankingPercentile
All
491
out of 12,415
96th
Division
Manufacturing
159
out of 5,505
97th
Major group
Chemicals And Allied Products
48
out of 2,375
98th
Industry group
Drugs
43
out of 2,096
98th
Industry
Pharmaceutical Preparations
25
out of 1,546
98th

Pay ratio

Bruce C. Cozadd's Pay$15,679,311
Median Employee's Pay$212,134
Pay Ratio

74

to 1

In 2021, the annual total compensation of Bruce C. Cozadd was $15,679,311.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.

The ratio of Bruce C. Cozadd's pay to the pay of median employee was therefore 74 to one.

Source: SEC filing on June 10, 2022.

Cozadd's colleagues

We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2021.

2021

Daniel Swisher

Jazz Pharmaceuticals

President

2021

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2021

Chris Tovey

Jazz Pharmaceuticals

Chief Operating Officer

2021

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like